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    Hospitalists manage many geriatric patients and 
one of the most challenging populations can be 
older adults with Parkinson’s Disease (PD) or other 
Parkinsonian disorders.  These patients are prone to 
complications such as delirium, falls and adverse 
effects of medications.  However, there are some 
basic principles that may improve our efforts to care 
for them. 
   Home Medications.  Patients with PD often take 
complex medication regimens, using agents with which internists may be unfamiliar.  
Commonly prescribed antiparkinsonian medications include carbidopa/levadopa 
(Sinemet), dopamine agonists [pramipexole (Mirapex), ropinirole (Requip)], COMT 
inhibitors [entacapone (Comtan)] and MAO inhibitors (selegiline and rasagline).  Pa-
tients often take these mediations on complex schedules that have been developed 
over years and may have problems with parkinsonian symptoms, dyskinesias or other 
adverse effects if the medications are not taken as prescribed.  The home dosing 
schedule should be replicated in the hospital setting and should involve coordination 
with nursing and pharmacy, with orders specifying the exact times of medication ad-
ministration (rather than typical TID or QID dosing).  Antiparkinsonism drugs should 
not be stopped abruptly as severe parkinsonism may ensue, including a “locked-in” 
rigid-bradykinetic state or even Neuroleptic Malignant Syndrome. 
   Medications to Avoid.  The most important point to remember is that patients with 
parkinsonian disorders should not receive dopamine blocking drugs, including many 
antiemetics and antipsychotics, since they will exacerbate parkinsonian symptoms.  
Nausea is a common problem in PD and a side effect of Sinemet and other drugs; 
however, medications that block dopamine such as prochlorperazine (Compazine), 
promethazine (Phenergan) and metocloperamide (Reglan) should be avoided.  5-HT3 
receptor antagonists (ondansetron and others) can be used safely to control nausea.  
Delirium and psychosis are also frequently encountered in hospitalized older patients 
with PD but conventional antipsychotics such as haloperidol should be avoided.  
While atypical and second generation antipsychotics have less extrapyramidal  (cont)  
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(cont) side effects, they can still exacerbate parkinsonism.  If antipsychotic therapy is needed, quetiapine 
(Seroquel) is often well tolerated in low doses (starting with 12.5-25 mg) by PD patients.  Given their propen-
sity to develop delirium, older PD patients should not be treated with anticholinergic agents or benzodiaze-
pines, since they may trigger or exacerbate acute confusion and delirium. 
   Nonpharmacologic Interventions.  Patient with parkinsonism are prone to orthostatic hypotension, consti-
pation, urinary difficulties, falls and deconditioning.  Inpatient care should include a plan for early and daily 
mobilization with early involvement of physical and occupational therapists.  Indwelling catheters and other 
tethers should be avoided.  Nonmotor complications of PD, such as constipation, depression and orthostatic 
hypotension are generally treated as with other patients.  For patients with longstanding PD, complex medi-
cation regimens, disease complications or inability to take oral medications, early involvement of the pa-
tient’s neurologist or expert in movement disorders is advised. 
 
HOSPITALIST CONFERENCE & LUNCHEON 
MISSOURI ACP MEETING 
SATURDAY, SEPTEMBER 26, 12:15 PM 
TAN-TAR-A RESORT, LAKE OF THE OZARKS 
TOPIC: HOSPITAL ACQUIRED INFECTIONS 
http://www.acponline.org/meetings/chapter/mo-2009.pdf     
 
 
CASE OF THE MONTH     Ahmad Tuffaha MD, UMKC 
P-ANCA Vasculitis in a Patient with Alpha-1-Antitrypsin Deficiency: A Possible Mechanism 
Introduction: 
Antineutrophil cytoplasmic antibody (ANCA) testing plays a critical role in the diagnosis and classification 
of vasculitis.  These antibodies are strongly associated with Wegener’s granulomatosis, microscopic poly-
angiitis and Churg-Strauss syndrome.  They are directed against a variety of autoantigens, including pro-
teinase 3 (PR3) and myeloperoxidase (MPO) [1].  On the other hand, alpha-1-antitrypsin (AAT) is the major 
inhibitor of PR3 while MPO is an inhibitor of AAT.  It is well known that AAT deficiency is associated with 
emphysema and liver disease.  The protein is encoded by a gene with multiple different alleles classified by 
the protease inhibitor (PI) system (PI*MM = homozygous normal, PI*ZZ = homozygous deficient).  The PI*ZZ 
phenotype carries a high risk for development of emphysema and liver disease [2].          (continued, page 3) 
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